COX-2: Where are we in 2003? - Distinction from NSAIDs becoming blurred
The distinction between cyclooxygenase-2-selective inhibitors (CSIs) and nonsteroidal anti-inflammatory drugs ultimately must be clinical and must be clinically and economically relevant. This distinction needs to be demonstrated in a substantial and clinically relevant difference in the respective...
Shranjeno v:
| izdano v: | Arthritis Res Ther |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2003
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC165043/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12723976/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/ar747 |
| Oznake: |
Brez oznak, prvi označite!
|